Saturday, December 31st, 2011 at 3:04 PM
If you are suffering from the deadly sleep disorder called the obstructive sleep apnea (OSA) then you’re not breathing properly while you sleep because your airflow is blocked repeatedly throughout the night.
Almost one in four men and one in ten women suffer from sleep apnea. There are three different types of sleep apnea but obstructive sleep apnea (OSA) is the most common. And it goes hand-in-hand with type 2 diabetes.
Among all of the sleep disorders, OSA has the strongest association with type 2 diabetes. That’s even taking into account other risk factors, such as weight, sex and age.
The main risk factor for OSA is obesity. Excess weight deposits extra fat around the thorax, reducing chest compliance and functional capacity, while increasing oxygen demand. Read the rest of this entry
Wednesday, October 19th, 2011 at 7:52 PM
Losing weight reduces the risk factors for many diseases, especially cardiovascular disease and type 2 diabetes and sleep apnea. Shedding just 10 pounds, for example, can lower blood pressure. Weight loss also lowers blood sugar and improves cholesterol levels.
Now, it looks like a new benefit can be added to the list. Losing weight can reduce urinary incontinence in women who are overweight or obese. In a randomized trial funded by the National Institutes of Health, moderate weight loss in a group of heavy women who undertook a six-month diet and exercise program cut the frequency of urinary incontinence episodes by nearly a half.
Urinary incontinence affects more than 13 million women in the United States. It not only causes inconvenience and emotional stress, it also raises the risk of falls, fractures, and nursing home admissions. Obesity has long been associated with urinary leakage in women, but until now, there’s been little research to confirm that losing weight would help reverse the problem — or to suggest how much weight loss would be needed. Read the rest of this entry
Sunday, September 25th, 2011 at 11:26 PM
Obstructive sleep apnea (OSA) is a common yet underdiagnosed condition. The aim of our study is to test whether prediabetes and type 2 diabetes are associated with obstructive sleep apnea (OSA) in extremely obese (BMI [greater than or equal to] 40 kg/m2) subjects.
One hundred and thirty seven consecutive extremely obese patients (99 females) from a controlled clinical trial [MOBIL-study (Morbid Obesity treatment, Bariatric surgery versus Intensive Lifestyle intervention Study) (ClinicalTrials.gov number NCT00273104)] underwent somnography with Embletta(R) and a 2-hour oral glucose tolerance test (OGTT). Read the rest of this entry
Saturday, June 18th, 2011 at 11:12 PM
According to the U.S. Department of Health and Human Services, more than 45 million Americans suffer from sleep apnea, a disorder that causes a person to briefly and repeatedly stop breathing during sleep. Obstructive Sleep Apnea (OSA) is a debilitating, often life-threatening sleep disorder an estimated 800 thousand patients are being diagnosed with OSA per year in the USA and approximately 10% being treated.
According to Jim Boyle a Registered Respiratory Therapist and Sleep Disorder Specialist with 20 years clinical experience has treated hundreds of OSA suffers and is the genesis behind NuLungs.com. People with untreated sleep apnea are more likely to have a heart attack, stroke, high blood pressure, congestive heart failure and Type II diabetes. Boyle founded the Company to offer a convenient and cost effective alternative to diagnosing and treating sleep apnea patients. Read the rest of this entry
Wednesday, June 15th, 2011 at 8:11 PM
Obstructive sleep apnea (OSA) is associated with obesity, insulin resistance (IR) and diabetes. Continuous positive airway pressure (CPAP) rapidly mitigates OSA in obese subjects but its metabolic effects are not well-characterized.
The researchers postulated that CPAP will decrease IR, ghrelin and resistin and increase adiponectin levels in this setting.
In a pre- and post-treatment, within-subject design, insulin and appetite-regulating hormones were assayed in 23 20 obese subjects with OSA before and after 6 months of CPAP use. Primary outcome measures included glucose, insulin, and IR levels.
Other measures included ghrelin, leptin, adiponectin and resistin levels. Body weight change were recorded and used to examine the lationship between glucose regulation and appetite-regulating hormones. Read the rest of this entry
Tuesday, June 7th, 2011 at 9:56 PM
Men who have type 2 diabetes in addition to obstructive sleep apnea seem to benefit from a regular exercise regimen, a new study has found.
Greater endurance from consistent physical activity can significantly boost survival rates for men with both conditions, researchers found. The findings are significant since the prevalence of sleep apnea, which commonly occurs in people with diabetes and high blood pressure, is on the rise, the study authors noted.
“Recent findings suggest that patients with sleep apnea have an increased risk of dying of any cause compared with individuals without sleep apnea,” study co-author Dr. Skikha Khosla, an endocrinologist at the Washington, D.C. Veterans Affairs Medical Center and George Washington University, said in a news release from the Endocrine Society. Read the rest of this entry
Monday, June 6th, 2011 at 7:59 PM
SleepApneaDisorder/[ Press Release]/ Philadelphia, Pennsylvania / Childhood obesity in Pennsylvania is at 29.7% according to the National Conference of State Legislatures. Pennsylvania weight loss problems mount as the state will pay $4.138 billion in annual medical costs of obesity.
One in three children are overweight or obese. If one’s child is overweight or obese, would they give them HCG weight loss? BMI (Body Mass Index) greater than 30 = obesity.
Childhood obesity has increased over 300% in the past 30 years according to the CDC (Center for Disease Control). Obesity among children aged 6 to 11 years increased from 6.5% in 1980 to 19.6% in 2008. Obesity among adolescents aged 12 to 19 years increased from 5.0% to 18.1% during the same time period. Read the rest of this entry
Saturday, June 4th, 2011 at 12:17 AM
Obesity remains a major problem in the Coastal Bend, a troubling statistic because of its association with sleep apnea , type 2 diabetes, heart disease and stroke, a regional health study found.
Nearly two-thirds of the 500 people surveyed were overweight or obese, a statistic that did not surprise health care and social service providers interviewed for the study, according to the 2010 Coastal Bend Community Health Needs Assessment.
The providers said the most frequent condition they saw in the past year was obesity and overweight patients, according to the study. Read the rest of this entry
Sunday, May 29th, 2011 at 1:24 PM
If you are suffering from sleep apnea disorder then you’re not breathing properly while you sleep because your airflow is blocked repeatedly throughout the night.
Nearly one in four men and one in ten women suffer from the sleep apnea disorder . There are three specific types of sleep apnea disorder but Obstructive sleep apnea (OSA) is the most common among them. Among all of the sleep disorders, OSA goes hand-in-hand with type 2 diabetes.
In a survey on the subject it was revealed that the obstructive sleep apnea (OSA) has the strongest association with type 2 diabetes.” That’s even taking into account other risk factors, such as weight, sex and age. Read the rest of this entry
Tuesday, May 24th, 2011 at 8:28 PM
SleepApneaDisorder/[ Press Release ]/ SAN DIEGO, May 24, 2011 /- ResMed today released the ResMed Sleep Assessment app, a novel new app for iPhone that lets users record themselves during sleep. The app also includes a clinically validated questionnaire that assesses their risk and other helpful features to empower users to discuss their sleep health with their physician.
Excessive tiredness may be due to sleep apnea
Feeling excessively tired or fatigued is often the result of disrupted, unhealthy sleep. Numerous factors can lead to poor quality sleep, some of which have significant negative health effects. One possible cause of fatigue is sleep apnea, a common sleep disorder. People with sleep apnea report feeling like they’re living in a fog, and that no matter how much they sleep they still feel exhausted.
Sleep apnea is a serious health condition in which a person stops breathing temporarily during sleep. After several seconds, the brain triggers a wake-up response, causing the person to awaken gasping. These events may happen hundreds of times per night, though the sleeper usually won’t remember waking up. Often a spouse or partner will notice that the person snores loudly during sleep.
Sleep apnea affects approximately one in five U.S. adults, although it is estimated that as many as 80% of sleep apnea sufferers are undiagnosed and untreated. A known cause of hypertension, untreated sleep apnea has also been linked with type 2 diabetes, cardiovascular disease, depression and stroke. Read the rest of this entry
Tuesday, May 17th, 2011 at 10:55 PM
Scientists say sleep deprivation also slows your metabolism down as well. Researchers from Uppsala University in Sweden found that insomnia could encourage you to pile on the pounds by slowing down the rate at which the body burns calories.
Study leader Christian Benedict, said: ‘Our findings show that one night of sleep deprivation acutely reduces energy expenditure in healthy men, which suggests sleep contributes to the acute regulation of daytime energy expenditure in huma
Older studies have linked sleep deprivation with weight gain and also shown how disrupted sleep also disrupts levels of stress – and hunger-related hormones during waking hours. Read the rest of this entry
Tuesday, May 3rd, 2011 at 10:29 PM
Research into the link between diabetes and sleep patterns has revealed that people who suffer from the metabolic condition and who don’t sleep well have higher insulin resistance, and also find it more difficult to manage their diabetes.
The study, published in Diabetes Care, assessed the sleep of 40 people with type 2 diabetes over six nights, checking if they were suffering any problems with their sleep, such as insomnia, sleep apnea or snoring . They also provided blood samples so the researchers could analyse insulin and glucose levels .
It was found that the diabetics who were also poor sleepers had 23 per cent higher levels of blood glucose in the morning, as well as 48 per cent higher levels of blood insulin. For insulin resistance, these figures meant that poor sleepers with diabetes had 82 per cent higher insulin resistance than normal sleepers with diabetes. Want to learn how to help people to be relaxed and sleep well? Check out a bachelors in psychology.
Kristen Knutson, lead author on the study, commented “People who have a hard time controlling their blood glucose levels have a greater risk of complications. They have a reduced quality of life . And, they have a reduced life expectancy .”
Eve Van Cauter, co-author of the study, also said “This suggests that improving sleep quality in diabetics would have a similar beneficial effect as the most commonly used anti-diabetes drugs .” Diabetics are generally known to have worse sleep patterns than non-diabetics, and poor sleep has even been blamed as a potential risk factor for developing the disease.
Sunday, April 24th, 2011 at 7:37 PM
SleepApneaDisorder/[ Press Release ]/ San Diego, CA / April 24, 2011/ This software allows them to quickly generate life insurance quotes to individuals with pre existing health conditions. These types of conditions in the past-Diabetes Type 1 and 2, Hepatitis, Sleep Apnea, Epilepsy, etc.-would have at best slowed the process down by days or weeks and at worst would have prevented these individuals from getting term life insurance at all.
This software is accessible through their website: www.lifelinedirectinsurance.com. By generating rates from the top 1% of life insurance companies, Lifeline Direct Insurance is able to provide a wide variety of coverage types to all clients while maintaining a high level of quality. As all of the term life insurance companies they work with are well established with a track record of success and stability, Lifeline Direct Insurance Services is able to provide term life insurance quotes to their clients that will be extremely dependable. In times of financial instability, this is a reassuring fact to many consumers who have seen their assets shrink or disappear over the past 5 years. Read the rest of this entry
Thursday, April 7th, 2011 at 5:32 PM
A study by scientists at the University of Birmingham has found that people that have type 2 diabetes and do not sleep well are at a higher risk of complaints such as eye disease, foot problems and amputation .
The research involved monitoring 231 type 2 diabetes patients, 149 of which had obstructive sleep apnea (OSA), a sleep disorder resulting from disturbed breathing. They showed there were 48 per cent of those with eye damage in the obstructive sleep apnea (OSA) group, as compared with only 20 per cent in the group without obstructive sleep apnea (OSA). Read the rest of this entry
Thursday, March 31st, 2011 at 9:48 PM
QNEXA [kyoo-nek-suh] is an investigational drug candidate being developed to address weight loss, type 2 diabetes and obstructive sleep apnea. QNEXA is a once-a-day, proprietary, oral, controlled-release formulation of low-dose phentermine and topiramate, which is designed to decrease appetite and increase satiety (the sense of feeling full), the two main mechanisms that impact eating behavior. In phase 2 and 3 clinical data to date, patients taking QNEXA have demonstrated statistically significant weight loss, glycemic control, and improvement in cardiovascular risk factors, when used in combination with a diet and lifestyle modification program.
VIVUS is a biopharmaceutical company developing therapies to address obesity, sleep apnea, diabetes and male sexual health. The company’s lead product in clinical development, QNEXA®, has completed phase 3 clinical trials for the treatment of obesity and is currently being considered for approval by US and EU regulators. QNEXA® is also in phase 2 clinical development for the treatment of type 2 diabetes and obstructive sleep apnea. In the area of sexual health, VIVUS is in phase 3 development with avanafil, a PDE5 inhibitor being studied for the treatment of erectile dysfunction. For more information about the company, please visit www.vivus.com